Study: Many cancer drugs unproven 5 years after accelerated approval
Time:2024-05-01 14:39:24 Source:worldViews(143)
The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives?
In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years.
“Five years after the initial accelerated approval, you should have a definitive answer,” said Dr. Ezekiel Emanuel, a cancer specialist and bioethicist at the University of Pennsylvania who was not involved in the research. “Thousands of people are getting those drugs. That seems a mistake if we don’t know whether they work or not.”
The program was created in 1992 to speed access to HIV drugs. Today, 85% of accelerated approvals go to cancer drugs.
It allows the FDA to grant early approval to drugs that show promising initial results for treating debilitating or fatal diseases. In exchange, drug companies are expected to do rigorous testing and produce better evidence before gaining full approval.
Previous:Fraudsters target small businesses with scams. Here are some to watch out for
Next:Chris Pine dons plaid blazer to honor his hero Jeff Bridges at 49th Chaplin Award Gala in NYC
You may also like
- Proof you CAN outrun bad genes with just four lifestyle tweaks
- Highlights of First Vocational Skills Competition of Jiangxi in E China
- China Issues Special Stamps Marking Year of the Rabbit
- Villagers Get Access to Medical Treatment in Rural Areas in East China's Shandong
- WADA defends pick of Swiss prosecutor under scrutiny in review of Chinese swimmers case
- China Focus: COVID
- China to End Use of Digital Travel Code Starting Tuesday
- Chinese Astronauts Give Lecture from Space Station
- Eli Lilly, 3M rise; MicroStrategy, Chegg fall, Tuesday, 4/30/2024